Skye Bioscience, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $1.9K | $1.9K | — | — |
| FY2013 | $-14.5K | $-63.6K | $49.1K | — |
| FY2014 | $-1.8M | $-1.8M | $23.3K | $10.8K |
| FY2015 | $-3.7M | $-3.7M | $2.0K | $414.3K |
| FY2016 | $-3.6M | $-3.6M | $11.1K | $706.4K |
| FY2017 | $-3.3M | $-3.4M | $19.7K | $608.7K |
| FY2018 | $-3.9M | $-3.9M | $4.4K | $675.0K |
| FY2019 | $-6.0M | $-6.0M | — | $680.5K |
| FY2020 | $-6.1M | $-6.1M | $7.2K | $302.7K |
| FY2021 | $-6.5M | $-6.6M | $90.9K | $869.2K |
| FY2022 | $-12.7M | $-12.8M | $28.1K | $629.0K |
| FY2023 | $-14.0M | $-14.0M | $12.6K | $987.5K |
| FY2024 | $-25.2M | $-26.8M | $1.6M | $8.3M |
| FY2025 | $-43.1M | $-43.1M | $6.3K | $7.8M |